He SZ, et al. Leuk. Lymphoma (2015) cited as Ref 556 in DOI: 10.1038/s41392-020-0110-5 (Q9819)

From Wikibase.slis.ua.edu
Revision as of 15:45, 21 May 2020 by Admin (talk | contribs) (‎Created claim: Property:P105: 1406-1415, #quickstatements; #temporary_batch_1590074839150)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
He SZ, et al. Leuk. Lymphoma (2015) cited as Ref 556 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    He SZ
    0 references
    0 references
    2015
    0 references
    Leuk. Lymphoma
    0 references
    56
    0 references
    A phase 1 study of the safety pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed refractory or high-risk acute myeloid leukemia (English)
    0 references
    1406-1415
    0 references